U.S. stocks experienced fluctuations on October 20, 2023, but ultimately rebounded as concerns about the stability of regional banks and credit risks loomed large. The S&P...
Eli Lilly (NYSE: LLY) has reported promising results from a late-stage trial of its drug, Omvoh (mirikizumab-mrkz), aimed at treating patients with moderately to severely active...